The Ohio State University Medical CenterDorothy M. Davis Heart & Lung Research Institute
HOMEABOUT USCore LabsResearchPeopleContact
Dr. Periasamy
Research
Home > Research > Research Labs > Dr. Periasamy  
Thematic Programs
Research Labs
Dr. Rajagopalan
Dr. Periasamy
Dr. Alevriadou
Dr. Anderson
Dr. Binkley
Dr. Birmingham
Dr. Cooke
Dr. Crouser
Dr. Doseff
Dr. Kuppusamy
Dr. Marsh
Dr. Moldovan
Dr. Rovin
Dr. Sen
Dr. Strauch
Dr. Wewers
CBE

Periasamy Lab                                               

              
Muthu Periasamy, PhD

Professor and Chair
Dept. of Physiology and Cell Biology
The Ohio Sate UNiversity -Medical Center
Columbus,OH 43210
614-292-2310 (phone)
614-292-4888 (fax)

Lab Members:

Poornima Bhupathy, Graduate Research Associate
Anu Kalyanasundaram, Graduate Research Associate
Mei Chi, Post Doctoral Researcher
Yingbi Zhou, Research Scientist
Subash Gupta, Post Doctoral Researcher
Naresh Bal, Post Doctoral Researcher

Current Research

Research in our laboratory  is focused on identifying  molecular mechanisms underlying heart failure. Heart failure is a progressive disease affecting the myocardium, initially causing poor pumping function and eventually resulting in death. The  precise mechanisms that contribute to  heart failure is poorly understood and the available treatment can only prolong survival for short term. There is no real cure for heart failure and only a heart transplant can save the patient.
The heart is a muscular pump and the beat-to-beat function of the heart is controlled by a well-defined set of proteins. These proteins make up a) the contractile apparatus responsible for generating force (pumping) and b) sarcoplasmic reticulum (SR) Ca2+ transport proteins that regulate intracellular Ca2+ levels. The release and removal of calcium from the sarcoplasmic reticulum is responsible for activating the heart muscle to contract and relax (heartbeat). Studies show that changes in Ca2+ handling proteins and Ca2+ transport can be linked to cardiac dysfunction and heart failure. To determine how altered expression or activity of the SR Ca2+ ATPase (SERCA) pump causes disease we have been using transgenic mouse models with altered SERCA protein levels. We have shown that increased SERCA expression is beneficial and protects the myocardium against heart disease including ischemia reperfusion injury. Our laboratory uses a variety of techniques, including Genomics, Proteomics and calcium imaging in isolated myocytes. Our long-term goal is to identify relevant therapeutic targets, to prevent the development of Heart Failure.


The current areas of research include:
1) Role of SR Calcium ATPase in cardiac function and disease using genetically altered mouse models
 2) Regulation of SERCA pump by Phospholamban and Sarcolipin , two small inhibitory phosphoproteins
3)  Role of luminal SR proteins Calsequestrin, Triadin, and Junctin


 

 

 
DOROTHY M. DAVIS
HEART AND LUNG
RESEARCH INSTITUTE
473 West 12th Avenue
Columbus, Ohio 43210
p: 614.247.7766
f: 614.247.7799
e: hlri-webmaster@osumc.edu